Sustained store-operated calcium entry utilizing activated chromatin state leads to instability in iTregs
eLife · 06.12.2023 · 12
DOI: 10.7554/elife.88874 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 06.12.2023. Verfasst von Huiyun Lyu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Calcium, Chromatin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, National Natural Science Foundation of China, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Thymus-originated tTregs and in vitro induced iTregs are subsets of regulatory T cells. While they share the capacity of immune suppression, their stabilities are different, with iTregs losing their phenotype upon stimulation or under inflammatory milieu. Epigenetic differences, particularly methylation state of Foxp3 CNS2 region, provide an explanation for this shift. Whether additional regulations, including cellular signaling, could directly lead phenotypical instability requires further analysis. Here, we show that upon TCR (T cell receptor) triggering, SOCE (store-operated calcium entry) and NFAT (nuclear factor of activated T cells) nuclear translocation are blunted in tTregs, yet fully operational in iTregs, similar to Tconvs. On the other hand, tTregs show minimal changes in their chromatin accessibility upon activation, in contrast to iTregs that demonstrate an activated chromatin state with highly accessible T cell activation and inflammation related genes. Assisted by several cofactors, NFAT driven by strong SOCE signaling in iTregs preferentially binds to primed-opened T helper (T H ) genes, resulting in their activation normally observed only in Tconv activation, ultimately leads to instability. Conversely, suppression of SOCE in iTregs can partially rescue their phenotype. Thus, our study adds two new layers, cellular signaling and chromatin accessibility, of understanding in Treg stability, and may provide a path for better clinical applications of Treg cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Immunology, Beijing Key Lab for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
- Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China.
- IDG/McGovern Institute for Brain Research and School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
- MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
- Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China.
- Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute, University of Calgary, Calgary, Canada.
Förderung
- CIHR
- National Natural Science Foundation of China
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Lyu, H., Yuan, G., Liu, X., Wang, X., Geng, S., Xia, T., Zhou, X., Li, Y., Hu, X., & Shi, Y. (2023). Sustained store-operated calcium entry utilizing activated chromatin state leads to instability in iTregs. eLife, 12. https://doi.org/10.7554/elife.88874
Vancouver
Lyu H, Yuan G, Liu X, Wang X, Geng S, Xia T, et al. Sustained store-operated calcium entry utilizing activated chromatin state leads to instability in iTregs. eLife. 2023;12. doi:10.7554/elife.88874
BibTeX
@article{Lyu2023,
author = {Lyu, Huiyun and Yuan, Guohua and Liu, Xinyi and Wang, Xiaobo and Geng, Shuang and Xia, Tie and Zhou, Xuyu and Li, Yinqing and Hu, Xiaoyu and Shi, Yan},
title = {Sustained store-operated calcium entry utilizing activated chromatin state leads to instability in iTregs},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.88874}
}
EUVIMED